Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy?

J Gastrointest Cancer. 2015 Jun;46(2):161-5. doi: 10.1007/s12029-015-9690-7.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bile Duct Neoplasms / immunology*
  • Bile Duct Neoplasms / pathology
  • Bile Duct Neoplasms / therapy
  • Carcinoma, Hepatocellular / immunology*
  • Carcinoma, Hepatocellular / secondary
  • Carcinoma, Hepatocellular / therapy
  • Cholangiocarcinoma / immunology*
  • Cholangiocarcinoma / pathology
  • Cholangiocarcinoma / therapy
  • Combined Modality Therapy
  • Follow-Up Studies
  • Humans
  • Immunotherapy*
  • Liver Neoplasms / immunology*
  • Liver Neoplasms / pathology
  • Liver Neoplasms / therapy
  • Male
  • Middle Aged
  • Neoplasm Regression, Spontaneous / immunology*
  • Neoplasm Regression, Spontaneous / pathology
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies